B
오스테오닉
226400KOSDAQ58.0 / 100
Reference Date: 2026-10-23
Financial Score30.5 / 40
News Sentiment12.5 / 25
Momentum5.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health and PER is significantly undervalued vs. peers is also solid. Roughly flat over the past month, with no recent news.
Company InformationBased on 2025 Annual Report
Business Overview
Osteonic produces and sells medical devices (implants) made of metal or biocompatible materials, used for bone fixation, replacement, and adjustment in various body parts such as the skull, jaw, trauma sites, and joints. While metal-based products dominate sales, biocomposite materials are gaining increasing share.
Number of Employees
197people
Average Salary
41.5M KRW
Score Calculation Basis
Detailed Financial Score
PER
11.23Industry Average 15.006.5Point
Lower than industry avg (good)
PBR
1.28Industry Average 1.202.5Point
Higher than industry avg (caution)
ROE
11.82Industry Average 8.004.0Point
In line with industry avg
Debt Ratio
19.29Industry Average 100.008.0Point
Half of industry avg (excellent)
Trend 2023~20259.5 / 10 points
Revenue Growth Rate
3.0 / 3
Avg ▲27.9% (2-year basis)
Operating Profit Growth Rate
3.0 / 3
Avg ▲35.5% (2-year basis)
ROE Trend
3.5 / 4
Avg ROE 10.1% (improving, 3yr)
Detailed News Sentiment
0 totalPositive 0Neutral 0Negative 0
Detailed Momentum
52-week position1.0Point
Near 52w low (11%, downtrend)
Current 4,200Won52-week high 7,64052-week low 3,745
1-month return3.0Point
1m -0.36% (flat)
Volume trend1.0Point
Volume dry-up
Detailed Disclosure
2 totalPositive 0Neutral 2Negative 0
- Neutral단기차입금증가결정2026-10-22
- Neutral[기재정정]반기보고서 (2026.06)2026-09-29